• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Stereotactic body radiation therapy in patients with hepatocellular carcinoma:A mini-review

    2019-06-11 07:30:18SabineGerumAlexandraJensenFalkRoeder

    Sabine Gerum, Alexandra D Jensen, Falk Roeder

    Sabine Gerum, Department of Radiation Oncology, University Hospital LMU Munich,Munich, 81377, Germany

    Alexandra D Jensen, Department of Radiation Oncology, University Hospital Gie?en and Marburg, Marburg, 35043, Germany

    Falk Roeder, CCU Molecular Radiation Oncology, German Cancer Research Center,Heidelberg, 74626, Germany

    Falk Roeder, Department of Radiotherapy and Radiation Oncology, Paracelsus Medical University, Salzburg, 5020, Austria

    Abstract

    Key words:Hepatocellular carcinoma; Stereotactic body radiation therapy; Local-ablative treatment; Combination approaches; Mini-review

    INTRODUCTION

    Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and ranking as the third most common cause of cancer death[1]. Tumour resection or liver transplantation is the main curative treatment options. However, only a minority of patients are suitable candidates for surgical treatment due to major vascular involvement, large multifocal lesions or accompanying comorbidities such as poor liver function or associated problems[2]. In the past, inoperable cases have traditionally been regarded as incurable. Treatment paradigms have changed dramatically in favor of local treatments in the last decades though. Even in inoperable patients, there is now emerging evidence of survival benefit or potential cure in inoperable patients receiving local treatments[3,4]. In consequence, local therapies should be considered in patients not eligible for curative surgery, or as a part of a strategy to bridge patients awaiting liver transplantation according to common guidelines[5]. Local treatments are broadly classified into two categories:Arterially-directed and locally ablative therapies. Arterially directed therapies include transarterial chemoembolization(TACE), transarterial chemoembolisation with drug eluting beds (DEB-TACE), and selective internal radiotherapy (SIRT). Locally ablative techniques include radiofrequency ablation (RFA), percutaneous alcohol injection, microwave or (less invasive) Stereotactic body radiation therapy (SBRT). However, potential benefits of these treatments need to be weighed against the potential treatment-induced impairment of liver function or even liver failure especially in the presence of underlying liver disease as a primary cause of most primary hepatic malignancies[4].All of these treatments also have limitations and appropriate patient selection is crucial to achieve positive outcomes:Patients with multiple comorbidities or inadequate liver function are usually poor candidates for surgical inverventions[4],patients with lesions directly adjacent to major vessels or bile ducts are not well suited for RFA[6], and patients with portal vein thrombosis rarely qualify for TACE or SIRT[7].

    SBRT is an additional locally ablative treatment option for patients with HCC who are not eligible for resection or other local treatments. It can also be used to bridge waiting time in patients qualifying for transplantation or as part of multi-modality treatments with other liver- directed therapies[3]. In the absence of level I evidence,SBRT is not considered a standard in many guidelines, unfortunately. This minireview describes current SBRT techniques and summarizes published evidence regarding efficacy and toxicity as a single treatment or in combination with other liver-directed therapies.

    SBRT: INDICATIONS AND TECHNIQUES

    SBRT is a highly conformal technique of external beam radiation therapy (EBRT)delivering high radiation doses in a small number of fractions[8]. Tumour control is achieved by high doses per fraction leading to high biological effectiveness and hence increased cell kill. Due to sharp dose gradients outside the target volume, dose to adjacent organs at risk is effectively limited maintaining adequate organ function.Stereotactic radiotherapy was initially developed for treatment of small cerebral lesions as stereotactic radiosurgery (SRS), the same principle was developed further in order to treat extracranial lesions (SBRT = stereotactic body radiation therapy). SRS and SBRT have now been widely accepted as standard of care for the treatment of limited brain or lung metastases as well as for early stage non-small-cell lung cancer.Clinical studies could show that SRS/SBRT and surgical approaches yield comparable results[8-10]. Meanwhile, SBRT is increasingly used for treatment of liver, lymph node or bony lesions[4,11,12].

    In liver lesions, SBRT is usually indicated in patients with 1-3 lesions with a maximum diameter of 5-6 cm[13]who are not eligible for resection or other local therapies either as definitive or bridging therapy prior to transplantation[13].Preservation of adequate liver function is mandatory, which is estimated individually based on total liver volume, lesion size and number, prior treatments and current liver function[4,13]. In general, patients with liver cirrhosis Child Pugh class A and early B are suitable candidates. In contrast to RFA/TACE treatment, patients with lesions located close to the liver surface, directly adjacent to large vessels, or portal vein thrombosis as well as patients presenting with extensive ascites are still candidates for SBRT. In contrast, However, patients with lesions directly adjacent to structures with low radiation tolerance like small bowel or stomach are less good candidates because dose reduction may be necessary[4,14,15].

    Technically, SBRT is a form of precision external beam radiation therapy using minimal safety margins[8]. In consequence, accurate target delineation and treatment planning, precise patient positioning, careful image guidance and adequate motion management strategies are mandatory. Target delineation usually includes multimodality imaging such as multi-phase contrast-enhanced computed tomography (CT)and magnetic resonance imaging preferably with liver-specific contrast-agents (see Figure 1). Patient positioning may include supportive vacuum pillows or other immobilization devices. Treatment planning is usually performed using multi-field or rotational techniques (see Figure 2). On-board imaging usually includes at least threedimensional cone beam CT prior to each fraction. Unfortunately, HCCs are poorly visible in native CT scans and can therefore rarely be identified by linac-based imaging, hence perilesional placement of fiducials prior to treatment planning is commonly necessary[4,16,17]. Depending on respective SBRT strategy, 1-4 gold or platin markers are placed near the lesion under CT or ultrasound guidance. These markers can be easily identified with all common image-guidance procedures (especially cone beam-CT) and used for patient set-up as well as gating or tracking strategies[4].Exceptions can be made if SBRT is applied shortly following TACE and there is still adequate contrast enhancement of lipiodol or if clips from prior surgical resections are present in direct proximity to the current lesions[3,4], (see Figure 2).

    Apart from implantation of fiducial markers, SBRT represents a non-invasive treatment option. Motion mitigation may be managed by either internal target volume concepts (ITV) or gating/tracking strategies. In order to define the ITV, the lesion is delineated on different respiratory phases based on a contrast-enhanced fourdimensional CT. The ITV corresponds to the resulting enveloping volume, which includes each delineated lesion position during the respiratory cycle and can be treated without breathing control or gating. In patients with large respiratory excursions, abdominal compression devices may be used to reduce motion and therefore limit resulting absolute ITVs[18]. In gating strategies, lesion motion is either derived from continuous breathing detection by imaging or patient surface detection or continuously detected through electromagnetic transponders. Radiation is applied only during short phases of the breathing cycle when the specific lesion is within a specified position or corridor, tracking techniques model lesion motion with respect to the breathing cycle. Accuracy of the model is checked and corrected in real time feeding back to the treatment position. In consequence, the radiation beam moves with the target and according to the model utilizing the whole breathing cycle and thereby reducing overall treatment time as compared to gating strategies. Doses are typically prescribed to a lesion-surrounding isodose (i.e., 65% or 80%), resulting in inhomogenous dose distributions. The lesion center therefore intentionally receives significantly higher doses while doses fall off quite sharply outside of the target volume. In consequence, doses and toxicities in adjacent normal tissue are reduced(see Figure 2). A variety of dose prescription and fractionation schedules have been employed. Currently most centers use 3-6 fractions of 8-20 Gy each, depending on localization, lesion size and liver function[4]. In order to preserve adequate liver function following SBRT, attention needs to be paid to specifying and sparing a threshold volume of uninvolved liver (usually 700 mL). In addition, excessive doses to luminal structures must be avoided by keeping a minimum distance (i.e., 5mm) to the high-dose area within the lesion[4]. If adequately performed, acute side effects following SBRT are rare and generally mild. These include fatigue, transient elevation of liver enzymes or unspecific abdominal symptoms. Late toxicities may include radiation-induced liver disease resulting in impaired liver function, gastrointestinal side effects like ulceration or stenosis, biliary complications and rib fractures.However, high-grade toxicities were rare and usually lower than in comparable series using alternative locally-ablative techniques[19-21]. Close follow-up evaluations including repeated imaging (see Figure 3) are necessary in order to evaluate resultant toxicity and to detect early local or distant progression[3]. It is of note though that SBRT may induce several and characteristic types of tumor and surrounding tissuealterations over time which should not be confused with progressive disease. For example, Herfarthet al[22]described three distinct types of focal reactions on multiphase contrast-enhanced CT following SBRT in their landmark paper. All of those are subject to substantial change over time and correlated to applied dose but have to be distinguished from disease recurrence. Lesions treated by SBRT may show signs of activity like hypervascularisation, wash-out or absence of regression in size up to 12 mo after treatment without residual viable tumor as reported by Mendiratta-Lalaet al[23]. Tétreauet al[24]compared different criteria for response evaluation and found that RECIST (Response evaluation criteria in solid tumors) criteria were unsuitable for response assessment and were outperformed by EASL (European Association of Study of the liver) criteria at each point of time during available followup. Therefore, response assessment including decision-making for salvage treatments following SBRT should preferably be made by a multidisciplinary panel including experienced radiation oncologists.

    Figure 1 Hepatocellular carcinoma in segment Vlll at diagnosis.

    SBRT: CLINICAL EVIDENCE

    In recent years an increasing number studies have been published, including mainly small retrospective cohorts but also larger series and well-designed phase II trials, see Table 1. Comparison of published data is hampered by varying and inhomogenous inclusion criteria across these studies. In addition, most series include large numbers of patients/lesions receiving SBRT because they were not eligible for other local treatments options (anymore) and/or have been treated with other techniques multiple times before. In consequence, most SBRT series represent a negative preselection of patients ex ante as compared to series reporting on other local treatments mainly as the primary treatment option. Nevertheless, SBRT resulted in very encouraging local control (1-year LC 65%-100%) and overall survival rates (1-year OS 32%-94%) with low toxicity[14,25-39]. In addition to dose and fractionation[28,30,34], local control appears to be determined by lesion size[28,34]and number of lesions[1], while overall survival is strongly associated with general condition and liver function prior to treatment. Several groups have consistently shown clear survival benefits after SBRT in Child-Pugh class A (CP-A) patients when compared to CP-B patients[14,27,34,39].CP-B patients further suffered from significantly increased toxicity despite receiving lower SBRT doses and less aggressive fractionation schemes[14,27], thus possible benefits and risks of SBRT have to be considered carefully when selecting those patients for treatment.

    Direct comparisons of SBRT with other local treatment options are limited and analyses most commonly retrospective (see Table 2). Suet al[40]compared SBRT with surgery in a propensity score matched cohort. Only patients with adequate liver function (CP-A), relatively small lesions (median 3.3 cm) treated in primary situation were included in the analysis. Despite mature follow-up of these cohorts, the authors could not detect significant differences between these treatment modalities with regard to either local control or overall survival. However, they described significant differences in accompanying toxicity profiles. While surgically treated patients showed less nausea, SBRT patients suffered less often from bleeding and pain. Wahlet al[19]performed a retrospective comparison of SBRT and RFA in a series of 224 patients. Except for a distinctly higher rate of prior treatments in the SBRT group,both arms seemed comparable with respect to major prognostic factors. Again, nosignificant difference in local control and overall survival was found between the cohorts. While both treatment were similarly efficient in lesions < 2 cm, the analysis showed significantly improved local control in patients treated with SBRT for larger lesions[19]. Sapiret al[20]compared SBRT with TACE in a retrospective series including 209 patients. Both groups were comparable with respect to their baseline characteristics with two exceptions:patients in the SBRT group were more heavily pre-treated, while mean lesion diameter was higher in the TACE group. Keeping those limitations in mind, SBRT resulted in significantly increased local control (1-year LC 97%vs47%) and favourable toxicity profile although this benefit did not translate into a clear survival benefit (1-year OS 75%vs74%)[20].

    Figure 2 Treatment plan (prescription dose 3 × 12.5 Gy to 65% surrounding isodose).

    In summary, SBRT seems to result at least in similar local control and overall survival rates as compared to other local treatments while showing mainly favorable toxicity profiles based on currently available albeit limited evidence. Therefore, SBRT may represent a reasonable alternative to other local treatments and should be considered as potential treatment modality in multidisciplinary evaluations of suitable patients.

    SBRT COMBINED WITH OTHER TREATMENTS

    RFA/TACE

    Combination of SBRT with other local therapies for treatment of either the same or different lesions may result in synergistic effects[3]. In case of multifocal disease with several lesions of various sites and size, some lesions may be easily addressed by RFA while others (i.e., due to close proximity to major vessels) may profit from SBRT.When combining different approaches, invasive procedures should be scheduled first,as fiducials (which are often necessary for SBRT) can be implanted in the same session without risks of an additional intervention.

    Figure 3 Complete response 9 months after transarterial chemoembolization and stereotactic body radiation therapy.

    Combining TACE with SBRT in the treatment of the same lesion may offer several advantages (see Figure 1-3). Prior TACE may result in tumour response and hence smaller SBRT volume leading to potentially improved toxicity[4]. Chemotherapy as a component of TACE may act as a radiosensitizer also enhancing the radiation effect of SBRT[4], although this might be counterbalanced by tumor hypoxia induced by embolization. Lipiodol deposits placed during embolization can also serve as landmarks for image guidance in SBRT, which may potentially render fiducial placement unnecessary[3,4]. Indeed, small retrospective series have shown significant improvements regarding treatment response, local control, progression-free survival,and even overall survival by the addition of SBRT to TACE compared to TACE alone at least if lesion size exceeded 3 cm[41,42]. Kanget al[28]reported a prospective phase II trial using SBRT following TACE. Fifty patients with lesion size < 10 cm and CP-A or early CP-B cirrhosis were enrolled. Patients received SBRT in 3 fractions with 14-20 Gy per fraction. The group reported very encouraging 2-year local and overall survival rates of 95% and 69%. Toxicities of grade III or higher were observed in only 10% despite comparatively high doses. In summary, combination of TACE and SBRT seems to be a very promising approach, which is currently evaluated in several prospective trials.

    Sorafenib

    Although preclinical data suggested radiation-sensitizing effects of sorafenib[43],combination of Sorafenib with SBRT does not appear advisable. Prospective clinical trials reported discouraging toxicities:Bradeet al[44]conducted a phase I trial investigating SBRT with concurrent Sorafenib in CP-A patients unsuitable for standard local therapies. Nine out of 16 patients showed grade 3+ toxicity including 2 deaths. While 15 of 16 patients completed SBRT as planned, adherence to Sorafenib treatment was poor:Only 3 out of 16 patients completed treatment for the first 12 wk without modifications. The authors concluded that concurrent use of SBRT and Sorafenib should not be recommended. Based on the preclinical data they advocated in favor of evaluating a sequential approach, which is currently under investigation within a randomized trial (RTOG 112).

    SBRT AS BRIDGING TO TRANSPLANT

    Many patients who were initially eligible for liver transplantation unfortunately drop off waiting lists due to tumour progression. As a result, increasing attention is paid to bridging approaches to reduce this number. Based on limited evidence from retrospective analyses, SBRT seems to be a reasonable option. For example, Katzet al[45]reported 18 patients treated with SBRT as bridging approach. All patients received 50 Gy in 10 fractions. 6 patients were delisted due to various reasons while the remaining 12 finally received major surgery or transplant after a median of 6.3 months. No grade 3+ toxicities were reported. Pathologic complete response rate in explanted organs following SBRT was 20%. Local control until transplantation was achieved in all patients. With a median follow-up of 20 mo, all patients are diseasefree and alive. O′Connoret al[46]similarly described a series of 11 patients with median lesion size of 3.4 cm who received SBRT with 33-54 Gy in 3 fractions as bridging.Patients underwent liver transplantation after a median interval of 113 d. Again no patient experienced grade 3+ toxicity. Pathologic complete response was found in 27% and 5-year DFS and OS after transplantation were 100%. Interestingly, patients receiving 54 Gy in 3 fractions showed a distinctly higher pathologic complete response rate of 60%. Mohamedet al[21]evaluated various bridging strategies including RFA, TACE, SBRT and SIRT. They found high pathologic complete response rates for all bridging treatments but noticed favorable toxicity profiles for SBRT and SIRT (no grade 3+ toxicity). Finally, Murrayet al[4]noted in a recent reviewthat 63%-100% of patients treated with SBRT as bridging proceeded to transplantation with explants showing pathologic complete and partial responses in 14%-27% and 23%-64% of lesions.

    Table 1 Prospective trials and large ( > 100 patients) retrospective series evaluating stereotactic body radiation therapy in hepatocellular carcinoma

    In summary, SBRT seems to be another suitable option to bridge patients scheduled for liver transplant, which shows similar response rates but very modest toxicity profiles as compared to other local treatment options and should be considered in the multidisciplinary evaluation.

    FUTURE DIRECTIONS

    Future developments regarding SBRT mainly focus on MRI-based treatment planning followed by real-time MRI-guided radiation therapy. The implementation of daily image guidance and replanning using MR-linac technology with enhanced soft-tissue information may not only result in increased set-up accuracy. It may however, allow omission of fiducial placement prior to SBRT, thus rendering SBRT a completely noninvasive treatment option. Furthermore, particle therapy (protons or heavy ions)seems to be a promising option due to higher biological effectiveness (heavy ions) and dosimetric advantages. However, the main benefit of protons (the lack of exit dose)may be offset in liver tumors by several factors:Meticulous motion mitigation techniques are crucial in order to minimize range uncertainties caused by moving airsoft-tissue or air-bony interface. Air-filled cavities in adjacent luminal organs presentfurther challenges[47]. Nevertheless, several reports describing early experiences with protons have shown high local control rates and low toxicities[48,49]. The potential benefit is currently evaluated in a phase III trial (NRG-GI003) comparing photon and proton SBRT in unresectable HCC[47].

    Table 2 Studies comparing stereotactic body radiation therapy to other local treatments

    CONCLUSIONS

    Evidence comparing various strategies for the treatment of HCC is limited. Based on available data, SBRT is an effective treatment option for HCC accompanied by low rates of toxicity. Outcomes seem at least comparable to other local treatment options or limited (non-transplantation) surgical approaches. Combination with other local therapies especially TACE appears to be feasible and seems to result in synergistic effects. SBRT may also be reasonably used as a bridging option in patients awaiting liver transplantation. Dose and fractionation should be prescribed individually based on liver volume, lesion size and number, prior treatments, current liver function and adjacent organs at risk and adequate patient selection is crucial.

    国产男女内射视频| 久久久久国产精品人妻一区二区| 亚洲色图综合在线观看| 高清av免费在线| 日韩不卡一区二区三区视频在线| 免费高清在线观看视频在线观看| 亚洲精品视频女| 成人毛片a级毛片在线播放| 国产av精品麻豆| 人体艺术视频欧美日本| 老司机影院毛片| 一个人看视频在线观看www免费| 久久毛片免费看一区二区三区| 成年女人在线观看亚洲视频| 免费人成在线观看视频色| 午夜免费观看性视频| 亚洲三级黄色毛片| 久久久久久久久久久丰满| 亚洲精品国产av蜜桃| 91精品国产九色| 色视频www国产| 国产美女午夜福利| 乱系列少妇在线播放| 五月天丁香电影| 日韩亚洲欧美综合| 老司机影院成人| 亚洲精品日本国产第一区| 一本久久精品| 国产精品嫩草影院av在线观看| 日本欧美国产在线视频| 国产精品熟女久久久久浪| 丝袜脚勾引网站| 日本欧美国产在线视频| 人妻少妇偷人精品九色| 亚洲国产色片| 国内精品宾馆在线| 简卡轻食公司| 最近的中文字幕免费完整| 午夜激情福利司机影院| 99热全是精品| 香蕉精品网在线| 99热这里只有精品一区| 在线观看人妻少妇| 少妇被粗大的猛进出69影院 | 亚洲精品第二区| 麻豆成人午夜福利视频| 最近的中文字幕免费完整| 国产精品蜜桃在线观看| videos熟女内射| 中文字幕人妻熟人妻熟丝袜美| 亚洲第一av免费看| 黄色欧美视频在线观看| 国产精品人妻久久久久久| 熟女av电影| 久久鲁丝午夜福利片| 久久国产精品大桥未久av | 久久韩国三级中文字幕| 99久久综合免费| 亚洲av免费高清在线观看| 亚洲欧美一区二区三区国产| 亚洲精品456在线播放app| 中文字幕人妻熟人妻熟丝袜美| 另类亚洲欧美激情| 国产黄片美女视频| 全区人妻精品视频| 久久久午夜欧美精品| 人人妻人人澡人人看| 亚洲av男天堂| 多毛熟女@视频| 国产高清国产精品国产三级| 国产高清有码在线观看视频| 亚洲欧美清纯卡通| 日韩 亚洲 欧美在线| 国产精品伦人一区二区| 亚洲欧美日韩另类电影网站| 国产精品人妻久久久久久| 久久av网站| 看十八女毛片水多多多| 亚洲av欧美aⅴ国产| 免费人妻精品一区二区三区视频| 亚洲精品久久久久久婷婷小说| 婷婷色综合大香蕉| 人人妻人人澡人人看| 日本vs欧美在线观看视频 | 亚洲欧美清纯卡通| 最近2019中文字幕mv第一页| 免费看日本二区| 国产乱人偷精品视频| a级一级毛片免费在线观看| 久久精品国产亚洲av涩爱| 插逼视频在线观看| 日韩一本色道免费dvd| 3wmmmm亚洲av在线观看| 日日撸夜夜添| 狂野欧美激情性xxxx在线观看| 在线观看免费高清a一片| 大香蕉97超碰在线| 久久精品国产亚洲网站| 99久久人妻综合| 99久久精品一区二区三区| 亚洲欧美日韩东京热| 午夜福利在线观看免费完整高清在| 日日啪夜夜撸| 久久久久精品久久久久真实原创| 国产男人的电影天堂91| 伦理电影免费视频| 亚洲精品久久午夜乱码| 一级毛片我不卡| 下体分泌物呈黄色| 国产69精品久久久久777片| 内地一区二区视频在线| 成人综合一区亚洲| 少妇高潮的动态图| 在线观看av片永久免费下载| 亚洲欧洲国产日韩| 免费久久久久久久精品成人欧美视频 | videos熟女内射| 久热这里只有精品99| 国产一区二区三区综合在线观看 | 好男人视频免费观看在线| 99久久精品国产国产毛片| 亚洲精品中文字幕在线视频 | 久久热精品热| 日本wwww免费看| 亚洲内射少妇av| av国产久精品久网站免费入址| 国产视频内射| 一级爰片在线观看| 一个人看视频在线观看www免费| 免费观看在线日韩| 最黄视频免费看| 久久久国产一区二区| 热re99久久国产66热| 在线免费观看不下载黄p国产| 丝袜喷水一区| 十八禁网站网址无遮挡 | 一级毛片我不卡| 狂野欧美白嫩少妇大欣赏| 亚洲综合精品二区| 亚洲精品中文字幕在线视频 | 青春草视频在线免费观看| 久久精品熟女亚洲av麻豆精品| 亚洲精品一区蜜桃| 日韩一区二区视频免费看| 国产精品.久久久| 久久免费观看电影| 99久久中文字幕三级久久日本| 丰满迷人的少妇在线观看| 黄色视频在线播放观看不卡| 日韩视频在线欧美| 你懂的网址亚洲精品在线观看| 久久精品国产自在天天线| 青春草亚洲视频在线观看| 日本欧美国产在线视频| 亚洲不卡免费看| 国产在线免费精品| 日韩av在线免费看完整版不卡| 精品午夜福利在线看| 国产免费一区二区三区四区乱码| 免费看av在线观看网站| 尾随美女入室| 久久免费观看电影| 亚洲精品色激情综合| videossex国产| 晚上一个人看的免费电影| 免费看不卡的av| 成人亚洲欧美一区二区av| 极品人妻少妇av视频| 国产黄片视频在线免费观看| 亚洲精品第二区| 日韩在线高清观看一区二区三区| 国产免费一级a男人的天堂| 亚洲伊人久久精品综合| 一区二区三区四区激情视频| 久热久热在线精品观看| 伦精品一区二区三区| 午夜日本视频在线| 夫妻午夜视频| 国产美女午夜福利| av专区在线播放| 在线观看av片永久免费下载| 黑人猛操日本美女一级片| 国产精品熟女久久久久浪| 少妇高潮的动态图| 伦理电影大哥的女人| 国产午夜精品久久久久久一区二区三区| 久久午夜综合久久蜜桃| 91精品国产国语对白视频| 欧美国产精品一级二级三级 | 精品国产一区二区三区久久久樱花| 91午夜精品亚洲一区二区三区| 成人特级av手机在线观看| 国产精品嫩草影院av在线观看| 久久久国产欧美日韩av| av福利片在线观看| 少妇丰满av| 久久99热这里只频精品6学生| 建设人人有责人人尽责人人享有的| 精品一品国产午夜福利视频| 亚洲欧美精品自产自拍| 精品一区二区免费观看| 国产免费一区二区三区四区乱码| 国产精品久久久久久久久免| 亚洲国产精品999| 一级,二级,三级黄色视频| 亚洲精品国产色婷婷电影| 日韩亚洲欧美综合| 国产淫语在线视频| 欧美日韩一区二区视频在线观看视频在线| 日本午夜av视频| 人人澡人人妻人| 超碰97精品在线观看| 中文资源天堂在线| 在线观看免费日韩欧美大片 | 国产日韩一区二区三区精品不卡 | 久久人人爽av亚洲精品天堂| 中文字幕精品免费在线观看视频 | 亚洲av福利一区| 一区二区三区免费毛片| 国产日韩欧美亚洲二区| 女人久久www免费人成看片| 最新的欧美精品一区二区| 97在线视频观看| 日本黄色片子视频| 亚洲欧美成人精品一区二区| 汤姆久久久久久久影院中文字幕| 欧美国产精品一级二级三级 | 男人舔奶头视频| 国产国拍精品亚洲av在线观看| 热99国产精品久久久久久7| 新久久久久国产一级毛片| 美女脱内裤让男人舔精品视频| 久久久久久久久大av| 中文字幕精品免费在线观看视频 | 精品少妇久久久久久888优播| 亚洲av综合色区一区| 91精品一卡2卡3卡4卡| 22中文网久久字幕| 久久久精品94久久精品| a 毛片基地| 80岁老熟妇乱子伦牲交| av网站免费在线观看视频| 自拍欧美九色日韩亚洲蝌蚪91 | 日韩av不卡免费在线播放| 日韩av免费高清视频| 亚洲精品第二区| av有码第一页| 精品一区二区免费观看| 国产片特级美女逼逼视频| 欧美精品高潮呻吟av久久| 国产av精品麻豆| 大片电影免费在线观看免费| 久久午夜福利片| 欧美日韩亚洲高清精品| 国产在线免费精品| 桃花免费在线播放| 午夜老司机福利剧场| 欧美一级a爱片免费观看看| 久久久久久久久久久久大奶| 偷拍熟女少妇极品色| 欧美日韩亚洲高清精品| 色94色欧美一区二区| 少妇人妻久久综合中文| 午夜福利影视在线免费观看| 99热这里只有是精品50| 久久热精品热| 天堂8中文在线网| 成年av动漫网址| 国产男女超爽视频在线观看| 女人精品久久久久毛片| 精品一区二区三区视频在线| 亚洲人成网站在线观看播放| 午夜av观看不卡| 午夜老司机福利剧场| 高清在线视频一区二区三区| 欧美三级亚洲精品| 丰满乱子伦码专区| 极品教师在线视频| 欧美区成人在线视频| 国产欧美另类精品又又久久亚洲欧美| 国内精品宾馆在线| 久久久欧美国产精品| 69精品国产乱码久久久| 91久久精品国产一区二区成人| 成年av动漫网址| 夫妻性生交免费视频一级片| 亚洲精品色激情综合| 黄色视频在线播放观看不卡| 国产探花极品一区二区| 搡女人真爽免费视频火全软件| 美女cb高潮喷水在线观看| 久久狼人影院| 黄片无遮挡物在线观看| 毛片一级片免费看久久久久| 亚洲精品乱码久久久v下载方式| 边亲边吃奶的免费视频| 久久99热这里只频精品6学生| 高清在线视频一区二区三区| 亚洲精品自拍成人| 精品少妇久久久久久888优播| 免费黄网站久久成人精品| 大话2 男鬼变身卡| 激情五月婷婷亚洲| 国产精品伦人一区二区| 欧美三级亚洲精品| 亚洲av电影在线观看一区二区三区| 亚洲国产欧美日韩在线播放 | 亚洲va在线va天堂va国产| 日韩欧美一区视频在线观看 | 不卡视频在线观看欧美| 我的女老师完整版在线观看| 国产精品久久久久久精品电影小说| 夜夜爽夜夜爽视频| 亚洲在久久综合| 亚洲精品日韩av片在线观看| 精品卡一卡二卡四卡免费| 秋霞伦理黄片| 国产精品福利在线免费观看| 久久6这里有精品| 久久久久久人妻| 亚洲在久久综合| 777米奇影视久久| 韩国高清视频一区二区三区| 成人免费观看视频高清| 亚州av有码| 欧美3d第一页| 日韩熟女老妇一区二区性免费视频| 自拍欧美九色日韩亚洲蝌蚪91 | 如日韩欧美国产精品一区二区三区 | 国产精品不卡视频一区二区| 日本wwww免费看| 熟女人妻精品中文字幕| 一个人看视频在线观看www免费| 久久久久视频综合| 国产精品99久久99久久久不卡 | 亚洲精品成人av观看孕妇| 欧美+日韩+精品| 国内揄拍国产精品人妻在线| av不卡在线播放| 国产精品人妻久久久久久| 久久久久精品久久久久真实原创| 国产老妇伦熟女老妇高清| 亚洲精华国产精华液的使用体验| av福利片在线| 能在线免费看毛片的网站| 久久狼人影院| 午夜av观看不卡| 亚洲欧美清纯卡通| 久久久精品免费免费高清| 国产欧美日韩综合在线一区二区 | 80岁老熟妇乱子伦牲交| 久久精品国产自在天天线| 亚洲国产最新在线播放| 精品视频人人做人人爽| 少妇人妻一区二区三区视频| 大香蕉97超碰在线| 欧美+日韩+精品| 又大又黄又爽视频免费| av女优亚洲男人天堂| 国产白丝娇喘喷水9色精品| 夫妻午夜视频| 亚洲图色成人| 欧美亚洲 丝袜 人妻 在线| 亚洲高清免费不卡视频| 午夜免费男女啪啪视频观看| 免费播放大片免费观看视频在线观看| 日韩亚洲欧美综合| 久久久欧美国产精品| 日韩大片免费观看网站| 久久精品久久久久久久性| 亚洲国产精品一区二区三区在线| 少妇裸体淫交视频免费看高清| 在线观看人妻少妇| 婷婷色麻豆天堂久久| 18禁在线无遮挡免费观看视频| 少妇的逼水好多| 日韩大片免费观看网站| 成人二区视频| 欧美xxⅹ黑人| 少妇裸体淫交视频免费看高清| 成人综合一区亚洲| 免费观看a级毛片全部| 亚洲综合精品二区| 午夜福利,免费看| 亚州av有码| 香蕉精品网在线| 三级国产精品欧美在线观看| 综合色丁香网| 亚洲第一av免费看| 国产一区二区在线观看日韩| 亚洲国产精品成人久久小说| 免费大片黄手机在线观看| av一本久久久久| 在线观看人妻少妇| 亚洲美女黄色视频免费看| 人人澡人人妻人| 久久精品国产亚洲av天美| 最新的欧美精品一区二区| 王馨瑶露胸无遮挡在线观看| 少妇被粗大的猛进出69影院 | 美女主播在线视频| 少妇猛男粗大的猛烈进出视频| h视频一区二区三区| 最黄视频免费看| a 毛片基地| 久久国产精品大桥未久av | a级一级毛片免费在线观看| 亚洲怡红院男人天堂| 狂野欧美白嫩少妇大欣赏| 久久久久久久久久人人人人人人| av一本久久久久| 成人美女网站在线观看视频| 26uuu在线亚洲综合色| 日韩一区二区三区影片| 插逼视频在线观看| 久久人人爽av亚洲精品天堂| 日本91视频免费播放| 婷婷色综合大香蕉| 熟女人妻精品中文字幕| 人体艺术视频欧美日本| 日本av手机在线免费观看| 秋霞伦理黄片| av免费在线看不卡| 欧美 日韩 精品 国产| 男人舔奶头视频| 夜夜骑夜夜射夜夜干| 亚洲在久久综合| 精品久久国产蜜桃| 丝袜喷水一区| 美女主播在线视频| 免费黄色在线免费观看| 全区人妻精品视频| av在线播放精品| 日韩成人伦理影院| 啦啦啦在线观看免费高清www| 久久久久久久国产电影| 亚洲av国产av综合av卡| 99久久精品国产国产毛片| 波野结衣二区三区在线| 人人澡人人妻人| 午夜免费观看性视频| 最近最新中文字幕免费大全7| 99热这里只有精品一区| 免费人妻精品一区二区三区视频| 午夜福利影视在线免费观看| 国产精品.久久久| 国产视频首页在线观看| 国产成人精品一,二区| 搡女人真爽免费视频火全软件| 性色av一级| 亚洲av中文av极速乱| 曰老女人黄片| 美女脱内裤让男人舔精品视频| 天堂8中文在线网| 久久婷婷青草| 日韩强制内射视频| av在线app专区| 美女主播在线视频| 天堂俺去俺来也www色官网| 天堂中文最新版在线下载| 久久 成人 亚洲| 午夜福利,免费看| 午夜视频国产福利| 亚洲精品亚洲一区二区| 婷婷色综合www| 女性生殖器流出的白浆| 国产综合精华液| 久久久精品免费免费高清| 日韩伦理黄色片| 老司机亚洲免费影院| 免费人成在线观看视频色| 91午夜精品亚洲一区二区三区| 最新中文字幕久久久久| 人人妻人人添人人爽欧美一区卜| 国产在视频线精品| 99热这里只有是精品在线观看| 丁香六月天网| 另类亚洲欧美激情| 又大又黄又爽视频免费| 精品人妻熟女av久视频| 国产高清不卡午夜福利| 国产精品女同一区二区软件| 精品一区二区三卡| 中国三级夫妇交换| 蜜桃久久精品国产亚洲av| 亚洲天堂av无毛| 国产无遮挡羞羞视频在线观看| 男人舔奶头视频| a 毛片基地| 男女免费视频国产| 亚洲av免费高清在线观看| 欧美区成人在线视频| 免费观看性生交大片5| 熟女av电影| 成人18禁高潮啪啪吃奶动态图 | 国产美女午夜福利| 成人毛片60女人毛片免费| 一本一本综合久久| 熟女电影av网| 亚洲高清免费不卡视频| 黄色配什么色好看| 日韩成人av中文字幕在线观看| 久久av网站| 久久久久人妻精品一区果冻| 国产在线男女| 男女国产视频网站| h视频一区二区三区| 大码成人一级视频| 成人美女网站在线观看视频| 搡女人真爽免费视频火全软件| 亚洲精品国产av蜜桃| 永久网站在线| 视频中文字幕在线观看| 在线播放无遮挡| 青春草亚洲视频在线观看| 欧美老熟妇乱子伦牲交| av一本久久久久| 97超碰精品成人国产| 精品一区在线观看国产| 欧美高清成人免费视频www| 国产视频首页在线观看| 精品一品国产午夜福利视频| 大片电影免费在线观看免费| 男女无遮挡免费网站观看| 亚洲欧洲日产国产| 久久精品熟女亚洲av麻豆精品| 一边亲一边摸免费视频| 黄色欧美视频在线观看| 一级a做视频免费观看| 国产伦精品一区二区三区四那| 色哟哟·www| 国产精品国产av在线观看| 亚洲内射少妇av| 亚洲三级黄色毛片| √禁漫天堂资源中文www| 赤兔流量卡办理| 一级毛片电影观看| 91精品一卡2卡3卡4卡| 亚洲国产精品一区三区| 午夜福利,免费看| 黄色怎么调成土黄色| 国产成人freesex在线| 久久久久久久精品精品| 久久久久国产网址| 国产成人a∨麻豆精品| 免费av不卡在线播放| 精品少妇内射三级| 久久女婷五月综合色啪小说| 美女内射精品一级片tv| 久久国产精品大桥未久av | 久久久久久久久久人人人人人人| 精品久久久精品久久久| av.在线天堂| 99久国产av精品国产电影| 大话2 男鬼变身卡| 日韩 亚洲 欧美在线| 男女啪啪激烈高潮av片| 国产日韩欧美视频二区| 亚洲av中文av极速乱| 在线观看www视频免费| 日韩中字成人| 国产爽快片一区二区三区| 美女国产视频在线观看| 欧美精品高潮呻吟av久久| 在线观看三级黄色| 99久久精品一区二区三区| 亚洲精品国产成人久久av| 国产伦理片在线播放av一区| 日本av手机在线免费观看| 伦理电影大哥的女人| 18禁在线无遮挡免费观看视频| 欧美三级亚洲精品| 丝袜脚勾引网站| 汤姆久久久久久久影院中文字幕| 丰满饥渴人妻一区二区三| 少妇人妻一区二区三区视频| 亚洲av不卡在线观看| 日韩不卡一区二区三区视频在线| 日本91视频免费播放| 少妇的逼好多水| 国产又色又爽无遮挡免| 人人妻人人添人人爽欧美一区卜| 伦理电影大哥的女人| 99久国产av精品国产电影| 伊人亚洲综合成人网| 少妇熟女欧美另类| 欧美日韩精品成人综合77777| 久久久久久人妻| 99久久中文字幕三级久久日本| 免费人成在线观看视频色| 日韩强制内射视频| 在线精品无人区一区二区三| 久久青草综合色| 精品国产一区二区三区久久久樱花| 亚洲精品日本国产第一区| 国产极品天堂在线| 欧美 日韩 精品 国产| 日本wwww免费看| 国产精品麻豆人妻色哟哟久久| 一级毛片电影观看| www.av在线官网国产| 亚洲综合精品二区| 日韩av不卡免费在线播放| 美女视频免费永久观看网站| 精品国产一区二区久久| 日本欧美视频一区| 久久ye,这里只有精品| 国产成人精品福利久久| 99久久精品国产国产毛片| 最新的欧美精品一区二区| 蜜桃久久精品国产亚洲av| 五月玫瑰六月丁香| 国产成人一区二区在线| videossex国产| 久久热精品热|